Clinical Trials Directory

Trials / Completed

CompletedNCT00720915

D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months

A Cohort Study to Test That There is a Low Risk of Recurrent VTE in Patients With a First Episode of Unprovoked VTE Who Stop Anticoagulant Therapy After 3 Months of Treatment in Response to Negative D-dimer Testing

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
410 (actual)
Sponsor
McMaster University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if the risk of recurrent venous thromboembolism (VTE) after stopping therapy is low and acceptable in patients with a first unprovoked proximal deep vein thrombosis (DVT) or pulmonary embolism (PE) who have completed 3 months of therapy and who have a negative D-dimer test on therapy and 1 month after stopping therapy.

Conditions

Interventions

TypeNameDescription
OTHERDiscontinue anticoagulant therapy (Negative d-dimer)Patients with negative d-dimer discontinue long-term anticoagulant therapy.
OTHERContinue on anticoagulant therapy (positive d-dimer)Patients with positive d-dimer continue or re-start on anticoagulant therapy

Timeline

Start date
2008-09-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2008-07-23
Last updated
2016-12-13

Locations

13 sites across 4 countries: United States, Canada, Ireland, United Kingdom

Source: ClinicalTrials.gov record NCT00720915. Inclusion in this directory is not an endorsement.